Migraine can be debilitating in children but often go undiagnosed because children have a more difficult time understanding and expressing their pain. View the video below to hear the Salinas family talk about their experience with the disorder.
Biohaven Pharmaceuticals is studying an investigational drug to potentially treat migraines in children and teens. If your child is between 6 and 17 years of age and has at least a 6-month history of migraine, they may qualify. Learn more about our pediatric migraine study.